dipyridamole has been researched along with DDD MPGNII in 18 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study investigates the influence of aspirin plus dipyridamole on proteinuria and renal function in nephrotic MPGN patients with moderately reduced glomerular filtration rate." | 9.07 | Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS) ( Böhler, J; Braun, N; Grupp, C; Heering, P; Schollmeyer, P; Zäuner, I, 1994) |
| "They found that in the course of treatment proteinuria did not change and glomerular filtration declined insignificantly." | 5.28 | [The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis]. ( Jáchymová, M; Knotková, V; Nĕmecek, K; Petrů, I, 1990) |
| " This study investigates the influence of aspirin plus dipyridamole on proteinuria and renal function in nephrotic MPGN patients with moderately reduced glomerular filtration rate." | 5.07 | Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS) ( Böhler, J; Braun, N; Grupp, C; Heering, P; Schollmeyer, P; Zäuner, I, 1994) |
| " This study investigates the effect of acetylsalicylic acid (ASA) combined with dipyridamole on proteinuria and renal function in nephrotic MPGN patients with normal/moderately reduced glomerular filtration rate (GFR)." | 3.71 | Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I. ( Baştürk, T; Harmankaya, O; Karabiber, N; Obek, A; Oztürk, Y, 2001) |
| " Ligustrazine with the dosage of 80 mg twice a day was given to 25 patients in the treatment group by intravenous perfusion besides the medicine used in the control group." | 2.71 | [Effect of ligustrazine on proliferative glomerulonephritis]. ( Tang, X, 2003) |
| " Corticosteroid dosage was then reduced according to clinical improvement." | 2.68 | Long-term corticosteroid and dipyridamole treatment of membranoproliferative glomerulonephritis type I in children. ( Matsutani, H; Niimura, F; Takeda, A, 1995) |
| "We enrolled 35 patients with MPGN type 1 who had a normal creatinine clearance at the time of their first renal biopsy and divided them into 2 groups based on clinical status at the time of their most recent examination: 12 patients with normal urine test results and 12 patients with minor urinary abnormalities at the latest observation (group 1) and 7 patients with persistent nephropathy and 4 patients with renal insufficiency (group 2)." | 1.33 | Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1. ( Hosoya, M; Isome, M; Kawasaki, Y; Suzuki, H; Takahashi, A; Tanji, M, 2005) |
| "Patients with type II MPGN are usually difficult to treat and often progress to endstage renal failure." | 1.32 | Long-term follow-up of type II membranoproliferative glomerulonephritis in two children. ( Iitaka, K; Iwasaki, N; Koshino, H; Moriya, S; Motoyama, O; Nakamura, S; Sakai, T, 2003) |
| "They found that in the course of treatment proteinuria did not change and glomerular filtration declined insignificantly." | 1.28 | [The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis]. ( Jáchymová, M; Knotková, V; Nĕmecek, K; Petrů, I, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 11 (61.11) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caltik, A | 1 |
| Demircin, G | 1 |
| Bülbül, M | 1 |
| Erdogan, O | 1 |
| Akyüz, SG | 1 |
| Arda, N | 1 |
| Harmankaya, O | 1 |
| Baştürk, T | 1 |
| Oztürk, Y | 1 |
| Karabiber, N | 1 |
| Obek, A | 1 |
| Iitaka, K | 1 |
| Nakamura, S | 1 |
| Moriya, S | 1 |
| Koshino, H | 1 |
| Iwasaki, N | 1 |
| Motoyama, O | 1 |
| Sakai, T | 1 |
| Tang, X | 1 |
| Kawasaki, Y | 1 |
| Hosoya, M | 1 |
| Takahashi, A | 1 |
| Isome, M | 1 |
| Tanji, M | 1 |
| Suzuki, H | 1 |
| Ratner, MIa | 1 |
| Fedorova, ND | 1 |
| Biriukova, LS | 1 |
| Makurov, AI | 1 |
| Takeda, A | 1 |
| Niimura, F | 1 |
| Matsutani, H | 1 |
| Cahen, R | 1 |
| Trolliet, P | 1 |
| Dijoud, F | 1 |
| Megri, K | 1 |
| François, B | 1 |
| Zäuner, I | 1 |
| Böhler, J | 1 |
| Braun, N | 1 |
| Grupp, C | 1 |
| Heering, P | 1 |
| Schollmeyer, P | 1 |
| Tanaka, S | 1 |
| Shirato, I | 1 |
| Inkyo-Hayasaka, K | 1 |
| Tanaka, A | 1 |
| Kubota, M | 1 |
| Nakayama, S | 1 |
| Tomino, Y | 1 |
| Nikiforova, OV | 1 |
| Kozlovskaia, NL | 1 |
| Rogov, VA | 1 |
| Zozulia, OV | 1 |
| Miroshnichenko, NG | 1 |
| Inaba, S | 1 |
| Tanizawa, T | 1 |
| Takahashi, T | 1 |
| Ishihara, S | 1 |
| Arai, M | 1 |
| Sakai, Y | 1 |
| Kurose, KK | 1 |
| Matsukura, H | 1 |
| Okada, T | 1 |
| Hirayama, A | 1 |
| Kikuchi, H | 1 |
| Hibino, T | 1 |
| Kobayashi, M | 1 |
| Yamaguchi, N | 1 |
| Iitsuka, T | 1 |
| Ngase, S | 1 |
| Aoyagi, K | 1 |
| Shimokama, T | 1 |
| Koyama, A | 1 |
| Tojo, S | 1 |
| Moriya, T | 1 |
| Nakazawa, K | 1 |
| Itoh, N | 1 |
| Shigematsu, H | 1 |
| Higuchi, M | 1 |
| Miyasaka, M | 1 |
| Oguchi, H | 1 |
| Dimitrakov, D | 1 |
| Simeonov, S | 1 |
| Despotov, T | 1 |
| Kumchev, E | 1 |
| Tsvetkova, Z | 1 |
| Nĕmecek, K | 2 |
| Petrů, I | 2 |
| Knotková, V | 2 |
| Jáchymová, M | 2 |
| Cieslar, P | 1 |
| Pelèska, J | 1 |
| Pick, P | 1 |
| Tomasy, M | 1 |
| Donadio, JV | 1 |
| Offord, KP | 1 |
3 trials available for dipyridamole and DDD MPGNII
| Article | Year |
|---|---|
[Effect of ligustrazine on proliferative glomerulonephritis].
Topics: Adolescent; Adult; Creatinine; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Fi | 2003 |
Long-term corticosteroid and dipyridamole treatment of membranoproliferative glomerulonephritis type I in children.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; | 1995 |
Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS)
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Blood Pressure; Dietary Proteins; | 1994 |
15 other studies available for dipyridamole and DDD MPGNII
| Article | Year |
|---|---|
An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy.
Topics: Administration, Oral; Adolescent; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Dipyridam | 2013 |
Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Creatinine; Dipyridamole; Drug | 2001 |
Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Topics: Basement Membrane; Biopsy; Child; Dipyridamole; Female; Follow-Up Studies; Glomerular Mesangium; Glo | 2003 |
Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Topics: Adolescent; Aspirin; Biomarkers; Biopsy; Calgranulin A; Calgranulin B; Child; Creatinine; Cyclophosp | 2005 |
[The therapy of mesangiocapillary glomerulonephritis].
Topics: Chlorambucil; Chronic Disease; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Glomerulone | 1995 |
Severe recurrence of type I membranoproliferative glomerulonephritis after transplantation: remission on steroids and cyclophosphamide.
Topics: Adult; Creatinine; Cyclophosphamide; Cyclosporine; Dipyridamole; Glomerulonephritis, Membranoprolife | 1995 |
Case report: late relapse in a case of mesangioproliferative glomerulonephritis.
Topics: Adult; Biopsy; Dipyridamole; Female; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative | 1996 |
[The successful therapy of an exacerbation of mesangioproliferative nephritis during pregnancy].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differ | 1995 |
Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
Topics: Adolescent; Adult; Biopsy; Child; Cyclophosphamide; Dipyridamole; Extracellular Matrix; Extracellula | 1996 |
[A case of glomerulonephritis with singular high titer of anticardiolipin antibody].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Anticoagulants; Dipyridamole; Female; | 1998 |
A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
Topics: Adolescent; Basement Membrane; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Fu | 1992 |
Effects of combined immunosuppressive, anticoagulant and antiaggregant treatment on the course of chronic membranoproliferative glomerulonephritis.
Topics: Adult; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, Membra | 1991 |
[The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis].
Topics: Adult; Aspirin; Chronic Disease; Dipyridamole; Female; Glomerular Filtration Rate; Glomerulonephriti | 1990 |
[Treatment of chronic proliferative glomerulonephritis using acetylsalicylic acid and dipyridamole].
Topics: Adult; Aspirin; Chronic Disease; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Female; Glom | 1989 |
Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis.
Topics: Adult; Aspirin; Child; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis | 1989 |